After surgical removal of the prostate to treat prostate cancer, clinicians monitor prostate specific antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked ...

A new study from UCLA researchers indicates that PSA levels with prostate cancer recurrence may not correlate with survival rates. PSA remains a useful tool in detecting prostate cancer and ...

Some men may be candidates for more prolonged PSA testing intervals. High PSA and short PSA double time are associated with a greater likelihood of a positive bone scan. PSA levels and kinetics ...

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...

On average, men's levels of prostate-specific antigen (PSA) decrease as their body mass index (BMI) rises, a new study shows.

A new urine test could help men with an elevated PSA, or prostate specific antigen, level avoid unnecessary biopsies and MRIs. The test screens for 18 genetic markers in the urine that are highly ...

Declines in prostate-specific antigen (PSA) level after treatment with the next-generation androgen receptor inhibitor drug enzalutamide predict improved survival rates in men with non-metastatic ...

Two of the most commonly used classes of medication—statins and nonsteroidal anti-inflammatory drugs (NSAIDs)—may compromise already controversial cancer screenings by lowering serum levels of ...